中财网 中财网股票行情
川宁生物(301301)财务分析指标    年份：
截止日期2026-03-312025-12-312025-09-302025-06-302025-03-31
营业总收入(万元)109449.84461626.96343598.43234858.40129694.96
营业收入(万元)109449.84461626.96343598.43234858.40129694.96
营业总成本(万元)95326.18367504.96268180.53178226.3094949.47
营业成本(万元)83666.67326595.67230897.69150626.4181275.61
净利润(万元)11072.7176929.8861139.3245485.8328821.85
归属于母公司的净利润(万元)11072.7176900.8961139.3245485.8328821.85
营业利润(万元)14244.8895698.7976793.6257543.1235333.18
利润总额(万元)13870.5293868.5875177.4855950.3235000.27
少数股东损益(万元)-70.93-66.27-48.92-28.26-1.19
基本每股收益(元)0.05(元)0.34(元)0.27(元)0.20(元)0.13(元)
稀释每股收益(元)0.05(元)0.34(元)0.27(元)0.20(元)0.13(元)
非经常性损益(万元)124.981080.11340.79-158.35517.97
扣除非经常性损益后净利润(万元)10947.7375820.7860798.5245644.1828303.89
总资产(万元)1040294.361042948.031033077.771015930.431073254.33
总负债(万元)218449.65232164.75237926.77237232.34252534.62
归属于母公司股东权益合计(万元)819379.03808246.68792597.03776843.47818838.02
股东权益合计(万元)821844.70810783.28795151.00778698.09820719.71
实收资本(股本)(万元)223008.50223008.50223008.50223008.50222716.00
资本公积(万元)329885.96329826.32329967.25329867.17328684.92
未分配利润(万元)224712.38213639.67207099.31191445.82234915.12
经营活动产生的现金流量净额(万元)18268.0954905.9557094.1339148.3811658.45
经营活动现金流入小计(万元)59789.43348692.81282725.41165289.4464816.35
经营活动现金流出小计(万元)41521.33293786.86225631.28126141.0653157.89
投资活动产生的现金流量净额(万元)-6944.90-23193.21-30197.20-4499.95-22250.15
投资活动现金流入小计(万元)55060.68279103.88192203.0596156.4620046.44
投资活动现金流出小计(万元)62005.58302297.09222400.25100656.4142296.59
筹资活动产生的现金流量净额(万元)-17881.72-67391.58-60905.48-62675.74-2875.14
筹资活动现金流入小计(万元)20000.0076812.6052012.541293.550.00
筹资活动现金流出小计(万元)37881.72144204.18112918.0163969.292875.14
期末现金及现金等价物余额(万元)66352.2273421.3374758.4880833.4895264.14
最后修改日期2026-04-232026-03-312025-10-282025-08-262025-04-29
↑返回页顶↑

转至川宁生物（301301）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。